-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
The Medicines for Children Research Network: building on current success as we move forward
Sabah G Attar, Vanessa Poustie & Michael W Beresford
Research Update: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
CONSORT 2010: progress and challenges
Larissa Shamseer, David Moher
Editorial: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
An approach to personalized medicine: the BATTLE trial
Niels Reinmuth & Michael Thomas
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Glucagon-like peptide-1 analogs in the treatment of Type 2 diabetes: a review of the Phase II and III trials
Marta Letizia Hribal, Giorgio Sesti
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation